308 related articles for article (PubMed ID: 17547754)
21. Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.
Ueda C; Nishikori M; Kitawaki T; Uchiyama T; Ohno H
Int J Hematol; 2004 Jan; 79(1):52-4. PubMed ID: 14979479
[TBL] [Abstract][Full Text] [Related]
22. Burkitt t(8;14)(q24;q32) and cryptic deletion in a CLL patient: report of a case and review of literature.
Reddy K; Satyadev R; Bouman D; Hibbard MK; Lu G; Paolo R
Cancer Genet Cytogenet; 2006 Apr; 166(1):12-21. PubMed ID: 16616107
[TBL] [Abstract][Full Text] [Related]
23. Illegitimate recombinations between c-myc and immunoglobulin loci are remodeled by deletions in mouse plasmacytomas but not in Burkitt's lymphomas.
Müller JR; Janz S; Potter M
Curr Top Microbiol Immunol; 1995; 194():425-9. PubMed ID: 7895518
[TBL] [Abstract][Full Text] [Related]
24. Variability of quantitative polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicenter study.
Darby AJ; Lanham S; Soubeyran P; Johnson PW
Haematologica; 2005 Dec; 90(12):1706-7. PubMed ID: 16330451
[TBL] [Abstract][Full Text] [Related]
25. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
26. [Epstein-Barr virus and Burkitt's lymphoma].
Joab I
Med Trop (Mars); 1999; 59(4 Pt 2):499-502. PubMed ID: 10901854
[TBL] [Abstract][Full Text] [Related]
27. [Involvement of chromosome 1, associated with t(8;14), in 2 cases of Burkitt's lymphoma and a case of ALL (L3)].
Del Potro E; Ferro MT; Díaz Mediavilla J; San Román C; Martínez R; Villegas A; Espinós D
Sangre (Barc); 1988 Feb; 33(1):39-43. PubMed ID: 3164113
[No Abstract] [Full Text] [Related]
28. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
Hu HM; Kanda K; Zhang L; Boxer LM
Leukemia; 2007 Apr; 21(4):747-53. PubMed ID: 17287852
[TBL] [Abstract][Full Text] [Related]
29. Forward and reverse changes in Ig/myc translocation carrying tumors.
Klein G
Princess Takamatsu Symp; 1989; 20():135-42. PubMed ID: 2562178
[TBL] [Abstract][Full Text] [Related]
30. Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC.
Zeidler R; Joos S; Delecluse HJ; Klobeck G; Vuillaume M; Lenoir GM; Bornkamm GW; Lipp M
Genes Chromosomes Cancer; 1994 Apr; 9(4):282-7. PubMed ID: 7519050
[TBL] [Abstract][Full Text] [Related]
31. Application of long PCR to detect t(8;14)(q24;q32) translocations in childhood Burkitt's lymphoma and B-ALL.
zur Stadt U; Hoser G; Reiter A; Welte K; Sykora KW
Ann Oncol; 1997; 8 Suppl 1():31-5. PubMed ID: 9187426
[TBL] [Abstract][Full Text] [Related]
32. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
[TBL] [Abstract][Full Text] [Related]
33. [Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
Fujishima N; Fujishima M; Inomata M; Yamanaka Y; Saitoh K; Kameoka Y; Yoshioka T; Saitoh H; Takahashi N; Hirokawa M; Sawada K
Rinsho Ketsueki; 2007 Apr; 48(4):326-31. PubMed ID: 17515125
[TBL] [Abstract][Full Text] [Related]
34. Topological organization of the MYC/IGK locus in Burkitt's lymphoma cells assessed by nuclear halo preparations.
Rätsch A; Joos S; Kioschis P; Lichter P
Exp Cell Res; 2002 Feb; 273(1):12-20. PubMed ID: 11795942
[TBL] [Abstract][Full Text] [Related]
35. Burkitt lymphoma with dual translocation of chromosome 14: a novel chromosomal abnormality of t(8;14),t(14;15).
Moon Y; Kim M; Park G
Ann Clin Lab Sci; 2008; 38(1):75-9. PubMed ID: 18316785
[TBL] [Abstract][Full Text] [Related]
36. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb.
Joos S; Falk MH; Lichter P; Haluska FG; Henglein B; Lenoir GM; Bornkamm GW
Hum Mol Genet; 1992 Nov; 1(8):625-32. PubMed ID: 1301171
[TBL] [Abstract][Full Text] [Related]
37. Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine.
Scapinello G; Pizzi M; Vio S; Nabergoj M; Visentin A; Martines A; Bonaldi L; Trentin L; Semenzato G; Piazza F
Ann Hematol; 2018 Oct; 97(10):2001-2003. PubMed ID: 29728736
[No Abstract] [Full Text] [Related]
38. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene.
Akasaka T; Akasaka H; Ueda C; Yonetani N; Maesako Y; Shimizu A; Yamabe H; Fukuhara S; Uchiyama T; Ohno H
J Clin Oncol; 2000 Feb; 18(3):510-18. PubMed ID: 10653866
[TBL] [Abstract][Full Text] [Related]
39. Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features.
Burmeister T; Schwartz S; Horst HA; Rieder H; Gökbuget N; Hoelzer D; Thiel E
Leukemia; 2005 Aug; 19(8):1391-8. PubMed ID: 15973450
[TBL] [Abstract][Full Text] [Related]
40. Translocations t(14;18) and t(8;14) with rearranged bcl-2 and c-myc in a case presenting as B-ALL (L3).
Brito-Babapulle V; Crawford A; Khokhar T; Laffan M; Matutes E; Fairhead S; Catovsky D
Leukemia; 1991 Jan; 5(1):83-7. PubMed ID: 1999960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
